This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2018 Nov;6(11):e55.

doi: 10.1016/S2213-2600(18)30422-3. Epub 2018 Oct 12.

No authors listed

Published Erratum

No authors listed. Lancet Respir Med. 2018 Nov.

. 2018 Nov;6(11):e55.

doi: 10.1016/S2213-2600(18)30422-3. Epub 2018 Oct 12.

No abstract available

Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial.
Rabe KF, Watz H, Baraldo S, Pedersen F, Biondini D, Bagul N, Hanauer G, Göhring UM, Purkayastha D, Román J, Alagappan VKT, Saetta M. Rabe KF, et al. Lancet Respir Med. 2018 Nov;6(11):827-836. doi: 10.1016/S2213-2600(18)30331-X. Epub 2018 Sep 14. Lancet Respir Med. 2018. PMID: 30224319 Clinical Trial.